European Journal of Cancer · 2019 · 214 citations · 124 references
MedicineDermatologyOncologyCutaneous OncologyImmunotherapyMedical OncologyAdjuvant TherapyCancer ImmunotherapyCancer StagingImmunotherapy For Skin CancerStaging Of Skin CancerSystemic Therapy For Skin CancerCutaneous Melanoma StagingDistant Metastasis StagingDistant Nodal MetastasisMelanoma Adjuvant TherapyMelanoma DiagnosisMelanoma ImmunotherapyMultimodal StagingTumor Board Decision-making
124
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott et al. · New England Journal of Medicine · 2010 · 15.2K citations · Full text
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer et al. · New England Journal of Medicine · 2012 · 12.7K citations · Full text
Life Sciences, Immunology, Oncology +17
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8.1K citations · Full text
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman, Axel Hauschild, Caroline Robert et al. · New England Journal of Medicine · 2011 · 7.7K citations · Full text
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert, Jacob Schachter, Georgina V. Long et al. · New England Journal of Medicine · 2015 · 5.8K citations · Full text